| Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations |
22 |
| Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults |
22 |
| A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions |
21 |
| Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents |
17 |
| Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings |
16 |
| Older adults' marijuana use, injuries, and emergency department visits |
15 |
| Testing hair for fentanyl exposure: a method to inform harm reduction behavior among individuals who use heroin |
12 |
| State-of-the-art behavioral and pharmacological treatments for alcohol use disorder |
11 |
| 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety |
10 |
| Gender differences in associations between pain-related anxiety and alcohol use among adults with chronic pain |
10 |
| Sex differences in daily life stress and craving in opioid-dependent patients |
9 |
| Combining medically assisted treatment and Twelve-Step programming: a perspective and review |
9 |
| Six policy lessons relevant to cannabis legalization |
8 |
| How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps |
8 |
| Epidemiology of harmful use of alcohol in Nigeria: a systematic review and meta-analysis |
8 |
| Drug use patterns and predictors among homeless youth: Results of an ecological momentary assessment |
8 |
| Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes |
7 |
| Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study |
7 |
| The mixed message behind Medication-Assisted Treatment for substance use disorder |
7 |
| Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users |
6 |
| Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV |
6 |
| Difficulties with emotion regulation, mindfulness, and substance use disorder severity: the mediating role of self-regulation of attention and acceptance attitudes |
6 |
| Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions |
6 |
| Homeless women's service use, barriers, and motivation for participating in substance use treatment |
6 |
| Cannabis legalization, regulation, & control: a review of key challenges for local, state, and provincial officials |
6 |
| Neuropsychological functioning in opioid use disorder: A research synthesis and meta-analysis |
5 |
| High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions |
5 |
| Impulsivity interacts with momentary PTSD symptom worsening to predict alcohol use in male veterans |
5 |
| Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers |
5 |
| The case for a medication first approach to the treatment of opioid use disorder |
5 |
| Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate |
5 |
| UPPS-P facets of impulsivity and alcohol use patterns in college and noncollege emerging adults |
5 |
| Neuromodulation with percutaneous electrical nerve field stimulation is associated with reduction in signs and symptoms of opioid withdrawal: a multisite, retrospective assessment |
5 |
| Changes in depression mediate the effects of AA attendance on alcohol use outcomes |
5 |
| Video game addiction, ADHD symptomatology, and video game reinforcement |
5 |
| Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain |
5 |
| Daily relationship between positive affect and drinking to cope: the moderating role of difficulties regulating positive emotions |
5 |
| Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives |
5 |
| Characteristics and experiences of buprenorphine-naloxone use among polysubstance users |
4 |
| Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users |
4 |
| Neuronal correlates of delay discounting in healthy subjects and its implication for addiction: an ALE meta-analysis study |
4 |
| The Self-perception of Text-message Dependency Scale (STDS): Psychometric update based on a United States sample |
4 |
| Perceived prevalence of peer marijuana use: changes among college students before and after Oregon recreational marijuana legalization |
4 |
| Self-awareness deficits associated with lower treatment motivation in cocaine addiction |
4 |
| Alcohol and tobacco use in men: the role of alexithymia and externally oriented thinking style |
4 |
| Recovery high schools: Effect of schools supporting recovery from substance use disorders |
4 |
| Pulmonary effects of inhaled cannabis smoke |
4 |
| Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain |
4 |
| Estimated blood alcohol concentrations achieved by consuming supersized alcopops |
4 |
| Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation |
4 |
